Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RNACRNAC
Showing 8 of 9 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CARTESIAN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 356,525 shares of RNAC (CARTESIAN THERAPEUTICS INC), worth $3.7M as of 2026-Q2. The position was increased (+35.2% shares). RNAC represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$3.7M

Current Shares

356,525

Total Value Change

+$1.5M

Total Shares Change

+220,825

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
356,525
+35.2%
$3.7M0.0%$10.42
34
2026-Q1
Increased
263,694
+3.2%
$1.6M0.0%$7.48
26
2025-Q4
Increased
255,539
+5.7%
$1.8M0.0%$6.94
27
2025-Q3
Increased
241,829
+10.5%
$2.5M0.0%$9.85
29
2025-Q2
Decreased
218,927
-2.9%
$2.3M0.0%$10.68
0
2025-Q1
Increased
225,500
+1.9%
$3M0.0%$14.54
27
2024-Q4
Increased
221,257
+63.0%
$4M0.0%$18.76
39
2024-Q3
Increased
135,700
+2.1%
$2.2M0.0%$17.00
26

Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used